Display Settings:


Send to:

Choose Destination
Am J Cardiol. 2006 Apr 17;97(8A):77C-81C. Epub 2006 Feb 3.

An assessment of statin safety by hepatologists.

Author information

  • 1Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. dcohen@partners.org


The purpose of the Liver Expert Panel was to provide advice to the National Lipid Association's (NLA) Safety Task Force in response to specific questions concerning liver-associated risks of statin therapy. The panel was composed of academic hepatologists with clinical and research interests in nonalcoholic fatty liver disease, lipid metabolic disorders, and drug hepatotoxicity.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk